Microbot Medical
MBOT
38 hedge funds and large institutions have $1.24M invested in Microbot Medical in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
1,300% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 1
52% more funds holding
Funds holding: 25 → 38 (+13)
32% more capital invested
Capital invested by funds: $933K → $1.24M (+$302K)
0.19% more ownership
Funds ownership: 6.33% → 6.52% (+0.19%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$103K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.1K |
| 3 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$13K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.2K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$9.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$58.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$42.5K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$12.3K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$978 |
| 5 |
ITIM
Indiana Trust & Investment Management
Mishawaka,
Indiana
|
-$805 |
MBOT Hedge Fund Activity: Q4 2024 in Review
38 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2024, worth a combined $1.24M — up 32% from $933K a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MBOT positions and 1 closed out — a net gain of 13 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $103K. The largest seller was AlphaCentric Advisors, cutting an estimated $58.7K.
- 38 institutional investors held Microbot Medical (MBOT) as of Q4 2024, up from 25 in Q3 2024.
- Funds reported $1.24M of Microbot Medical stock for Q4 2024, up 32% quarter-over-quarter.
- 14 funds opened new Microbot Medical positions in Q4 2024 and 1 closed out, a net change of +13 holders.
- The largest Microbot Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $103K added.
- The largest Microbot Medical seller in Q4 2024 was AlphaCentric Advisors, an estimated $58.7K sold.
Based on aggregated 13F filings for Q4 2024.